Comprehensive Study Notes: Antigen Recognition by B-Cell and T-Cell Receptors

THE STRUCTURE OF A TYPICAL ANTIBODY MOLECULE

IgG antibodies consist of four polypeptide chains (two heavy and two light chains) held together by disulfide bonds.
Immunoglobulin heavy and light chains are composed of constant regions and variable regions.
The domains of an immunoglobulin molecule have similar structures (immunoglobulin fold).
The antibody molecule can be cleaved into functionally distinct fragments by proteolysis.
The hinge region provides flexibility in binding to multiple antigens.
Structural arrangement (based on Figures 4.1a–4.1c):
- The N terminus contains the variable regions that form the antigen-binding site at the VH : VL interface.
- Heavy chain variable region (VH) pairs with light chain variable region (VL) to create the antigen-binding site; disulfide bonds link chains; constant regions (C) follow the variable domains (CH for heavy chain and CL for light chain).
- The heavy chain constant domains include CH1, CH2, CH3; the light chain constant domain is CL.
- The regions are designated as V (variable) and C (constant) for each chain, with N-terminus being variable and C-terminus being constant.
Functional fragments and cleavage (Figure 4.4):
- Papain cleavage yields two Fab fragments and one Fc fragment.
- Pepsin cleavage yields a single F(ab')_2 fragment and a pFc fragment.
The hinge region and fragment organization support antigen binding and effector functions:
- Fab fragments contain the antigen-binding sites.
- Fc fragment mediates effector functions (e.g., interaction with Fc receptors, complement activation).
Antibody structure details (from Figure references):
- N terminus: variable region; C terminus: constant region.
- Disulfide bonds connect heavy and light chains and stabilize variable/constant domain pairing.
- Carbohydrate moieties may be present on constant regions and can influence function.
Overall takeaway: antibodies have a modular Y-shaped structure with a variable antigen-binding region at the tips (composed of VH and VL) and constant regions that mediate effector functions; flexibility is provided by the hinge region.

THE INTERACTION OF THE ANTIBODY MOLECULE WITH SPECIFIC ANTIGEN

Localized regions of hypervariable sequence form the antigen-binding site (the paratope).
- Variability is concentrated in the heavy-chain V region and light-chain V region;
- Heavy-chain V region variability: HV1, HV2, HV3 with framework regions FR1–FR4 interspersed.
- Light-chain V region variability: HV1, HV2, HV3 with framework regions FR1–FR4 interspersed.
- The variable regions bring together three complementarity-determining regions (CDRs) per chain (CDR1, CDR2, CDR3) to create the antigen-binding site.
- The framework regions (FR1–FR4) provide structural support for the CDRs.
Antibodies bind antigens via contacts in CDRs that are complementary to the size and shape of the antigen (paratope–epitope fit).
Antibodies bind to conformational shapes on antigen surfaces using various noncovalent forces.
- Noncovalent forces include:
- Electrostatic forces (attraction between opposite charges)
- Hydrogen bonds
- Van der Waals forces
- Hydrophobic interactions (hydrophobic groups packing away from water; involves van der Waals forces as well)
- Cation–π interactions (between a cation and an electron cloud of a nearby aromatic group)
- These forces collectively stabilize the antigen–antibody interaction.
Antibody interaction with intact antigens is influenced by steric constraints (the physical fit and accessibility of epitopes).
Some species generate antibodies with alternative structures (antibody diversity across species).
Local variability visuals (from Figures 4.6–4.7):
- The heavy and light chain V regions show distinct patterns of variability across residues, with CDRs exhibiting the highest variability and contributing most to antigen contact.
- The HV1, HV2, HV3 regions correspond to CDR1–CDR3 regions in each chain and form the composite antigen-binding site.

ANTIGEN RECOGNITION BY T CELLS

The TCRα:β heterodimer is very similar to a Fab fragment of immunoglobulin (Figure 4.13).
A T-cell receptor recognizes antigen as a complex of a foreign peptide bound to an MHC molecule (Figure 4.12).
There are two classes of MHC molecules with distinct subunit compositions but similar three-dimensional structures (Figure 4.17 and related figures):
- MHC class I: consists of an α chain (α1, α2, α3) associated with β2-microglobulin; peptide-binding cleft formed by α1 and α2 domains; presents peptides to CD8+ T cells.
- MHC class II: consists of α and β chains forming a similar peptide-binding cleft; presents peptides to CD4+ T cells.
Peptides are stably bound to MHC molecules and serve to stabilize the MHC molecule on the cell surface.
MHC class I molecules bind short peptides of length $8-10$ amino acids by both ends (termini serve as anchors in the peptide-binding groove).
The length of peptides bound by MHC class II molecules is not constrained (can be longer and of variable length).
Crystal structures of peptide–MHC–TCR complexes show a similar orientation of the TCR over the peptide–MHC complex (conserved geometry across different peptide–MHC–TCR assemblies).
The CD4 and CD8 cell-surface proteins directly contact MHC molecules and are required to mount an effective T-cell response.
The two classes of MHC molecules are expressed differentially on cells (tissue distribution and cell-type expression):
- MHC class I is expressed on most nucleated cells; high on professional antigen-presenting cells (with specific patterns).
- MHC class II is expressed primarily on professional antigen-presenting cells (e.g., dendritic cells, macrophages, B cells).
A distinct subset of T cells bears an alternative receptor composed of γ and δ chains (γδ T cells) (Figure 4.31).
TCR structure details (Figures 4.14–4.15):
- TCRα and TCRβ chains have variable regions (Vα, Vβ) and constant regions (Cα, Cβ).
- A stalk segment and a transmembrane region link the extracellular TCR to the cell membrane; the cytoplasmic tail participates in signaling.
- Disulfide bonds stabilize chain pairing within the TCR heterodimer; carbohydrate modifications may be present on TCR components.
- The receptor architecture is reminiscent of an Fab fragment, highlighting shared principles of antigen recognition between B and T cell receptors.
CD4/CD8 co-receptors enhance TCR–MHC interactions and are essential for signal transduction and effective immune responses.
Differential expression of MHC classes across cell types underpins the division of labor between CD4+ helper T cells (MHC II) and CD8+ cytotoxic T cells (MHC I).
Practical implications and relevance:
- Understanding antigen recognition informs vaccine design, antibody therapies, and T-cell–based immunotherapies.
- The diversity generated in CDRs and MHC-binding repertoires underlies the ability to recognize a vast array of pathogens.
- Steric constraints, binding geometry, and noncovalent interaction types influence binding affinity and specificity.
Ethical/philosophical/practical considerations:
- Antibody and TCR diversity is a double-edged sword: essential for pathogen recognition but potential for autoimmunity and cross-reactivity.
- Therapeutic manipulation (e.g., monoclonal antibodies, TCR-engineered therapies) requires careful consideration of specificity, off-target effects, and immune system balance.
- Differential MHC expression across tissues influences transplant compatibility and susceptibility to immune surveillance.

ADDITIONAL CONTEXT AND KEY TERMINOLOGY

Antigen-binding site (paratope): the region of the antibody–antigen interface formed mainly by CDRs in the variable regions of heavy and light chains.
Complementarity-determining regions (CDRs): three hypervariable regions per variable domain (CDR1, CDR2, CDR3) that contact the antigen.
Framework regions (FRs): relatively conserved regions that scaffold the CDRs.
Hypervariable regions (HV): synonymous with CDRs describing the regions of highest variability.
Fab fragment: the antigen-binding fragment of an antibody comprising the variable regions and the first constant domain of each chain (heavy and light).
Fc fragment: the crystallizable fragment that mediates effector functions.
F(ab')_2 fragment: dimeric Fab fragment resulting from pepsin digestion, lacking Fc.
MHC (major histocompatibility complex): a set of cell-surface proteins that present peptide antigens to T cells; includes class I and class II.
TCR (T-cell receptor): antigen receptor on T cells; includes αβ and γδ forms; recognizes peptide–MHC complexes.
CD4/CD8: co-receptors that stabilize TCR–MHC interactions and participate in signaling.
g/d TCRs: TCRs with gamma and delta chains, representing a distinct T-cell lineage.
Numerical and structural details summarized from the chapter:
- MHC class I binds peptides of length $8-10$ amino acids by both ends.
- The hinge angle in an antibody can be demonstrated as 60^
  b0 or 90^b0 in micrographs illustrating arm orientation; these angles reflect classical representations of antibody flexibility (Figure 4.5).
- The TCR resembles a Fab fragment in overall architecture, reflecting conserved strategies for peptide–antigen recognition across B and T cell receptors.
This set of notes captures the major and minor points presented in the transcript, organized to support exam preparation and provide a comprehensive reference to antibody and TCR antigen recognition, MHC presentation, and the structural basis of adaptive immunity.